Page last updated: 2024-12-07

orotidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

orotidine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

orotidine : A nucleoside formed by attaching orotic acid to a ribose ring via a beta-N(1)-glycosidic bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92751
CHEBI ID25722
SCHEMBL ID20894
MeSH IDM0052805

Synonyms (28)

Synonym
314-50-1
orotidine
6-carboxyuridine
3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid
4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-beta-d-ribofuranosyl-
3-ribofuranosylorotic acid
unii-b350mc02gz
b350mc02gz ,
uridine-6-carboxylic acid
SCHEMBL20894
CHEBI:25722
3-.beta.-d-ribofuranosylorotic acid
orotidine [mi]
uridin-6-carboxylic acid
4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-.beta.-d-ribofuranosyl-
3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
orotidine, >=90% (hplc)
orotic acid riboside
HY-113226
CS-0059354
3-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
isobutylvalerate
uridine-6-carboxylicacid
Q10859719
F82233
6-hydroxy-2-oxo-3-pentofuranosyl-2,3-dihydropyrimidine-4-carboxylic acid
DTXSID90953435
AS-79205

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pyrimidinemonocarboxylic acid
uridines
nucleosideAn N-glycosyl compound that has both a nucleobase, normally adenine, guanine, xanthine, thymine, cytosine or uracil, and either a ribose or deoxyribose as functional parents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Biomarkers for pyrimidine metabolism disorders1432
Urea cycle and associated pathways2430
Pyrimidine metabolism and related diseases1844

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (40.38)18.7374
1990's16 (30.77)18.2507
2000's5 (9.62)29.6817
2010's6 (11.54)24.3611
2020's4 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.82 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index49.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (5.66%)5.53%
Reviews2 (3.77%)6.00%
Case Studies2 (3.77%)4.05%
Observational0 (0.00%)0.25%
Other46 (86.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]